287 related articles for article (PubMed ID: 19649919)
1. Influenza--the case for combination therapy.
Krystal MR; Meanwell NA
Curr Opin Investig Drugs; 2009 Aug; 10(8):746-9. PubMed ID: 19649919
[No Abstract] [Full Text] [Related]
2. Antiviral treatment for patients hospitalized with 2009 pandemic influenza A (H1N1).
Uyeki T
N Engl J Med; 2009 Dec; 361(23):e110. PubMed ID: 19923564
[No Abstract] [Full Text] [Related]
3. Antiviral resistance in influenza viruses--implications for management and pandemic response.
Hayden FG
N Engl J Med; 2006 Feb; 354(8):785-8. PubMed ID: 16495389
[No Abstract] [Full Text] [Related]
4. Use of neuraminidase inhibitors to combat pandemic influenza.
Democratis J; Pareek M; Stephenson I
J Antimicrob Chemother; 2006 Nov; 58(5):911-5. PubMed ID: 16956904
[TBL] [Abstract][Full Text] [Related]
5. Global transmission of oseltamivir-resistant influenza.
Moscona A
N Engl J Med; 2009 Mar; 360(10):953-6. PubMed ID: 19258250
[No Abstract] [Full Text] [Related]
6. Oseltamivir resistance: what does it mean clinically?
Baum SG
Clin Infect Dis; 2009 Dec; 49(12):1836-7. PubMed ID: 19911972
[No Abstract] [Full Text] [Related]
7. Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus.
van der Vries E; Stelma FF; Boucher CA
N Engl J Med; 2010 Sep; 363(14):1381-2. PubMed ID: 20879894
[No Abstract] [Full Text] [Related]
8. Neuraminidase inhibitors and their role in avian and pandemic influenza.
Crusat M; de Jong MD
Antivir Ther; 2007; 12(4 Pt B):593-602. PubMed ID: 17944267
[TBL] [Abstract][Full Text] [Related]
9. Drug resistance. A 'wimpy' flu strain mysteriously turns scary.
Enserink M
Science; 2009 Feb; 323(5918):1162-3. PubMed ID: 19251605
[No Abstract] [Full Text] [Related]
10. Antivirals for influenza: historical perspectives and lessons learned.
Hayden FG
Antiviral Res; 2006 Sep; 71(2-3):372-8. PubMed ID: 16815563
[TBL] [Abstract][Full Text] [Related]
11. Pandemic flu vaccine: are we doing enough?
Campbell JD
Clin Pharmacol Ther; 2007 Dec; 82(6):633-5. PubMed ID: 17998908
[TBL] [Abstract][Full Text] [Related]
12. Apropos "vaccines in a hurry".
Arya SC; Agarwal N
Vaccine; 2009 Aug; 27(36):4875. PubMed ID: 19560429
[No Abstract] [Full Text] [Related]
13. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus.
Rungrotmongkol T; Intharathep P; Malaisree M; Nunthaboot N; Kaiyawet N; Sompornpisut P; Payungporn S; Poovorawan Y; Hannongbua S
Biochem Biophys Res Commun; 2009 Jul; 385(3):390-4. PubMed ID: 19463784
[TBL] [Abstract][Full Text] [Related]
15. The truth about Tamiflu? Neuraminidase inhibitors in pandemic A/H1N1 flu.
Weber JT; Nicoll A; Bridges CB; Ciancio BC
BMJ; 2010 Jan; 340():c130. PubMed ID: 20071425
[No Abstract] [Full Text] [Related]
16. Antiviral management of seasonal and pandemic influenza.
Hayden FG; Pavia AT
J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384
[TBL] [Abstract][Full Text] [Related]
17. [The new pandemic influenza A/H1N1. Antiviral agents for the initial stage--vaccine reduces the effects in the long run].
Uhnoo I; Bergquist C
Lakartidningen; 2009 Jul 8-21; 106(28-29):1814-9. PubMed ID: 19685621
[No Abstract] [Full Text] [Related]
18. [Neuraminidase inhibitors in prophylaxis and treatment of influenza].
Nitsch-Osuch A; Brydak LB; Wardyn AK
Pol Merkur Lekarski; 2008 Jul; 25(145):67-73. PubMed ID: 18839619
[TBL] [Abstract][Full Text] [Related]
19. Implications of antiviral resistance of influenza viruses.
Monto AS
Clin Infect Dis; 2009 Feb; 48(4):397-9. PubMed ID: 19586376
[No Abstract] [Full Text] [Related]
20. Public health. Rethinking influenza.
Rappuoli R; Del Giudice G; Nabel GJ; Osterhaus AD; Robinson R; Salisbury D; Stöhr K; Treanor JJ
Science; 2009 Oct; 326(5949):50. PubMed ID: 19797644
[No Abstract] [Full Text] [Related]
[Next] [New Search]
